BamSEC and AlphaSense Join Forces
Learn More

Zeo ScientifiX Inc.

OTC: ZEOX    
Share price (12/20/24): $2.09    
Market cap (12/20/24): $13.8 million

Material Contracts Filter

EX-10.2
from 8-K 9 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 11 pages Employment Agreement
12/34/56
EX-10.3
from 8-K 12 pages Common Stock Purchase Warrant Organicell Regenerative Medicine, Inc
12/34/56
EX-10.2
from 8-K 24 pages Promissory Note
12/34/56
EX-10.1
from 8-K 26 pages Securities Purchase Agreement
12/34/56
EX-10.63
from 10-K 3 pages Material contract
12/34/56
EX-10.62
from 10-K 3 pages February 9, 2023 Mr. Albert Mitrani Re: February 2023 Amendment to August 2022 Amendment and Employment Agreement
12/34/56
EX-10.61
from 10-K 3 pages February 9, 2023 Dr. Maria Ines Mitrani Re: February 2023 Amendment to August 2022 Amendment and Employment Agreement
12/34/56
EX-10.15
from 8-K 10 pages Director Service Agreement
12/34/56
EX-10.2
from 8-K 14 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 27 pages Purchase Agreement
12/34/56
EX-10.14
from 8-K 2 pages Material contract
12/34/56
EX-10.13
from 8-K 10 pages This Warrant and the Shares of Common Stock Issuable Upon Exercise of This Warrant Have Not Been Registered Under the Securities Act of 1933, as Amended (The “Securities Act”) or Any State Securities Laws. This Warrant and the Common Stock Issuable Upon Exercise of This Warrant May Not Be Sold, Offered for Sale, Pledged or Hypothecated in the Absence of an Effective Registration Statement as to This Warrant Under the Securities Act and Any Applicable State Securities Laws or an Opinion of Counsel Reasonably Satisfactory to Organicell, Inc. That Such Registration Is Not Required or the Sale of Such Securities Is Made Pursuant to Securities and Exchange Commission (“SEC”) Rule 144
12/34/56
EX-10.12
from 8-K ~1 page August 19, 2022 1. the Consulting Arrangement Is Hereby Terminated and Is of No Further Force and Effect
12/34/56
EX-10.11
from 8-K 2 pages August 19, 2022 1. Section 3 of the Employment Agreement (Compensation) Shall Be Amended as Follows: (A) Sections 3(b), 3(c), 3(d), 3(f), 3(g), 3(h), 3(i), and 3(m) of the Employment Agreement Shall Be Deleted in Their Entirety. (B) Section 3(j) of the Employment Agreement (Car and Mileage Allowance) Is Amended to Limit Executive’s Car and Mileage and Car Insurance Allowances to $1,500 and $500 Per Month, Respectively, Based on Actual Costs Incurred. (C) Section 3(k) of the Employment Agreement (Cellular Telephone and Internet Allowance) Shall Be Amended to Limit Executive’s Monthly Cellular Telephone and Internet Service Allowance to $350. (D) the Last Paragraph of Section 3 of the Employment Agreement Relating to Health Insurance Coverage Is Amended to Provide That the Maximum Cost Payable by the Company or Reimbursable to Executive for Health Care Coverage Is $1,600 Per Month
12/34/56
EX-10.10
from 8-K 2 pages August 19, 2022 1. Section 3 of the Employment Agreement (Compensation) Shall Be Amended as Follows: (A) Sections 3(b), 3(c), 3(d), 3(e), 3(f), 3(g), 3(h), 3(i), 3(k) and 3(m) of the Employment Agreement Shall Be Deleted in Their Entirety. (B) Section 3(j) of the Employment Agreement (Car and Mileage Allowance) Shall Be Amended to Limit Executive’s Car and Mileage and Car Insurance Allowances to $1,500 and $400 Per Month, Respectively, Based on Actual Costs Incurred. (C) the Last Paragraph of Section 3 of the Employment Agreement Relating to Health Insurance Coverage Is Amended to Provide That the Maximum Cost Payable by the Company or Reimbursable to Executive for Health Care Coverage Is $900 Per Month. 2. Executive Waives the Right to Receive All Accrued but Unpaid Compensation as of the Date of This Letter Agreement, Except for Two Unpaid Base Salary Payments Which Were Outstanding as of July 31, 2022. 3. Section 6 of the Employment Agreement (Change in Control) Is Deleted in Its Entirety. 4. the Company and Executive Agree That Except as Amended or Modified Hereby, the Employment Agreement Is Ratified, Approved and Confirmed and Remains in Full Force and Effect
12/34/56
EX-10.9
from 8-K 2 pages August 19, 2022 1. Section 1 of the Employment Agreement (Position and Duties) Shall Be Amended to Provide That Executive Shall Serve as the Company’s Executive Vice President of Sales. 2. Section 3 of the Employment Agreement (Compensation) Shall Be Amended as Follows: (A) Sections 3(b), 3(c), 3(d), 3(e), 3(f), 3(g), 3(h), 3(i) and 3(m) of the Employment Agreement Shall Be Deleted in Their Entirety. (B) Section 3(j) of the Employment Agreement (Car and Mileage Allowance) Shall Be Amended to Limit Executive’s Car and Mileage and Car Insurance Allowances to $1,700 and $400 Per Month, Respectively, Based on Actual Costs Incurred. (C) Section 3(k) of the Employment Agreement (Cellular Telephone and Internet Allowance) Shall Be Amended to Limit Executive’s Monthly Cellular Telephone and Internet Service Allowance to $700. (D) the Last Paragraph of Section 3 of the Employment Agreement Relating to Health Insurance Coverage Is Amended to Provide That the Maximum Cost Payable by the Company or Reimbursable to Executive for Health Care Coverage Is $400 Per Month. 3. Executive Waives the Right to Receive All Accrued but Unpaid Compensation as of the Date of This Letter Agreement, Except for Two Unpaid Base Salary Payments Which Were Outstanding as of July 31, 2022. 4. Section 6 of the Employment Agreement (Change in Control) Is Deleted in Its Entirety
12/34/56
EX-10.8
from 8-K 10 pages Organicell Regenerative Medicine, Inc. Common Stock Purchase Warrant
12/34/56
EX-10.7
from 8-K 10 pages Organicell Regenerative Medicine, Inc. Common Stock Purchase Warrant
12/34/56
EX-10.6
from 8-K 5 pages Consulting Agreement
12/34/56